Table 2.
Characteristics of the studies selected for the meta-analysis on the relapse rate
| Author, year | Assessment times (yrs) | Patients (N) | Type of study | Recruitment period | classification Criteria | Criteria for relapse |
|---|---|---|---|---|---|---|
| Mørk C, 2020 [16] | 1 | 174 | R / P | 2012–2017 | Physician’s diagn | C, L |
| Ayano M, 2020 [31] | 1 | 32 | R | 2011–2017 | Bird’s | C, L, T |
| Do JG, 2018 [32] | 1 | 34 | R | 2009–2017 | ACR/EULAR | C, L |
| Mackie SL, 2015 [24] | 1 | 21 | R | NA | Bird’s | NS |
| Lee JH, 2013 [33] | 1 | 39 | R | NA | Bird’s | C, L |
| Macchioni 2009 [34] | 1 | 57 | P | NA | Descriptive | C, L |
| Weyand CM, 1999 [29] | 1 | 27 | P | 1993–1996 | Descriptive | NS |
Yrs, years. N, number. P, prospective. R, retrospective. NA, data not available. Rheum, rheumatology. Diagn., diagnosis. ACR, American College of Rheumatology. EULAR, European League Against Rheumatisms. C; clinical (reappearance or worsening of symptoms). L, laboratory (increased APRs). T, therapeutic (required increase of therapy)